In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note.

[1]  L. Weitner,et al.  Drug-resistant genotyping in HIV-1 therapy , 1999, The Lancet.

[2]  W. Gerlich,et al.  Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations , 1999, Journal of Clinical Microbiology.

[3]  R. D. de Man,et al.  Clinical impact of lamivudine resistance in chronic hepatitis B. , 1998, Journal of hepatology.

[4]  K. Walters,et al.  Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .

[5]  K. Chayama,et al.  Emergence and takeover of YMDD motif mutant hepatitis B virus during long‐term lamivudine therapy and re‐takeover by wild type after cessation of therapy , 1998, Hepatology.

[6]  Y. Cheng,et al.  Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance. , 1998, Biochemical pharmacology.

[7]  R. D. de Man,et al.  Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. , 1998, The Journal of infectious diseases.

[8]  J. Wands,et al.  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective , 1998, Hepatology.

[9]  S. Schalm.  Clinical implications of lamivudine resistance by HBV , 1997, The Lancet.

[10]  K. Reddy,et al.  Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation , 1997, The Lancet.

[11]  J. van Lunzen,et al.  Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment. , 1996, AIDS.

[12]  E. Schiff,et al.  A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.

[13]  H. Mitsuya,et al.  Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine. , 1995, Antiviral research.

[14]  T. Poynard,et al.  Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients , 1995, The Lancet.

[15]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[16]  C. Bréchot,et al.  Detection of Hepatitis B Virus DNA in Serum by a Simple Spot Hybridization Technique: Comparison with Results for Other Viral Markers , 2007, Hepatology.